You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202191 - 202200 of 207728 results
  1. Mobile App for Diabetic Retinopathy Screening using Cellphone Retinal Camera

    SBC: EYENUK, INC.            Topic: NEI

    DESCRIPTION (provided by applicant): In this SBIR project, we present EyeApp, a smartphone-based end-to-end point-of- care diabetic retinopathy diagnostic device comprising of a smartphone-attachable retinal imaging camera and validated software application enabling fully-automated screening of diabetic retinopathy (DR). DR is the leading cause of new-onset blindness in working-age adults in the i ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Novel Hydrocyanine Probes for the Accurate Detection of Reactive Oxygen Species

    SBC: LI-COR BIOSCIENCES, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) are involved in numerous cell-signaling pathways. They have been implicated in over 150 diseases including cancer, arthritis, Parkinson's disease, diabetes, myocardial infarction and atherosclerosis. The need to understand the role of ROS in these processes is evidenced by the 80,000 publications in this field during the last ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Cytometry Reagent Database and Automated Panel Design Software.

    SBC: FLUORISH, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): The proposed project described in this grant application, combined with existing Fluorish tools, will create a robust cloud-based e-commerce marketplace for cytometry research reagents, addressing key needs in the research community. Flow Cytometry is widely used in basic and clinical research. Fluorish LLC will streamline the experimental design process and e ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. ADSC Isolation by MMPs

    SBC: Akron Biotechnology, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Mesenchymal stem cells (MSCs) are known to have the capacity for self-renewal and differentiation into mesenchyme-lineage cell types, including osteoblasts, adipocytes, chondrocytes, tenocytes, and myoblasts, and contribute to the regeneration of a variety of mesenchymal tissues. Adipose tissue represents a rich source of mesenchymal stem cells, and provides an ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. New HILIC Materials for Separating Polar Drugs, Biologics, and Metabolites

    SBC: AZYP, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): The effective separation and analysis of pharmaceutical compounds and their metabolites is essential to researchers that develop new, more effective, safer, and economical medicines. Novel types of biologically deriveddrug compounds (biologics) are becoming more important and prevalent as they match and sometimes exceed the importance of traditional small synth ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Novel technology to remove obscuring blood from fine needle aspiration biopsies

    SBC: AFFINERGY, LLC            Topic: NIGMS

    SUMMARY/ABSTRACT Fine-needle aspiration (FNA) cytology is the standard technique for evaluating thyroid nodules. Hemorrhaging is common during the procedure, however, leading to an aspirate that is diluted by blood. Subsequent slide preparations are oftensuboptimal, resulting in nondiagnostic outcomes that necessitate additional testing or diagnostic surgery. In fact, quality is so unpredictable t ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Nanoparticulate Coatings Enhance Ion Detection

    SBC: IONWERKS INC            Topic: NIGMS

    DESCRIPTION (provided by applicant): A new thin film approach to increasing the gain and sensitivity of current and future fast particle detectors is hypothesized. An increased ion induced secondary electron yield at the first surface of the detector while retaining high timing accuracy will make such detectors suitable replacement for MCP detectors in biological applications such as electron or ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. High throughput camelid antibody screening as drug discovery platform

    SBC: ABZYME THERAPEUTICS LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Monoclonal antibodies are used for treatment of a wide range of diseases from cancer to infectious diseases. However, development of antibodies with high affinity and specificity is still time-consuming, labor-intensiveand unpredictable. Abzyme Therapeutics LLC is actively developing animal-free antibody discovery platforms to accelerate generation of therapeut ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. RNA-Guided Gene Targeting in Human Cells

    SBC: ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS            Topic: NIGMS

    Project Summary/Abstract The goal of the proposed Phase I research is to develop a set of commercial kits for footprint-free genome engineering. The core technologies that serve as the foundation of these kits are based on the CRISPR/cas system, which wasoriginally identified in bacteria and recently shown to also function in mammalian cells. The main advantage of the proposed gene targeting syste ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Cell-based Real Time Platform for GPCR Drug Discovery

    SBC: LUCIGEN CORPORATION            Topic: NIGMS

    Abstract High throughput screening assays for GPCR drug discovery are hampered by the complex instrumentation associated with current technologies, and the high risk of false-positives and off- target effects. The majority of currently available GPCR drugscreening assays are end-point assays that rely on secondary reporters of GPCR signaling events after signaling has occurred. These assays are fu ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government